InvestSMART

ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD
Current share price for RMD : $31.230 -4.85 (-13.44%)+
Announcement
Release
28 Apr 2025 8:08AM
Price at Release
$36.080
Full Release
download
Summary
For the quarter ended March 31, 2025, ResMed Inc. reported a net income of $365.0 million, reflecting a 21% increase compared to the same period in the previous year. Total net revenue for the quarter increased by 8% to $1,291.7 million, driven primarily by growth in the Sleep and Breathing Health and Residential Care Software segments. The company also noted improvements in diluted earnings per share, which rose to $2.48. Cash flow from operating activities significantly increased to $1,212.8 million, and the company maintained compliance with its debt covenants while managing a total cash and cash equivalents balance of $932.7 million.
Key Points
  • Net income for Q3 2025 was $365.0 million, up 21% from Q3 2024.
  • Total net revenue increased by 8% to $1,291.7 million.
  • Diluted earnings per share rose to $2.48.
  • Cash flow from operating activities increased to $1,212.8 million.
  • ResMed maintained compliance with debt covenants.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.